CAR- T and mobile genetics treatments are actually also costly

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and innovation transactions may deliver cellular gene treatments at a cost effective cost to individuals around the world.